As David B. Nash, MD, MBA, takes the helm of Disease Management as Editor-in-Chief, the practice of disease management—now a decade old—depends on its practitioners to continue to provide economic proof of concept. This effort to accrue the credibility needed to design and fund programs will provide further evidence that new technologies can be integrated into care programs across large populations to reduce costs while improving healthcare and access to it
David Nash, MD, MBA, is the Founding Dean and the Dr. Raymond C. and Doris N. Grandon Professor of H...
Disease Management (DM) programs for Medicaid patients with chronic diseases have become very popula...
IDPH has a new grant-funded program, the Health Promotion and Chronic Disease Control Partnership. ...
As David B. Nash, MD, MBA, takes the helm of Disease Management as Editor-in-Chief, the practice of ...
The 2005 Disease Management Colloquium was heald at Jefferson Medical College in Philadelphia on Jun...
The purpose of this article is to examine chief medical officers\u27 (CMOs) perception of disease ma...
David B. Nash is the Founding Dean of the Jefferson School of Population Health on the campus of Tho...
The successful management of diabetes with a goal of achieving near-normoglycemia requires patients ...
There is growing evidence that greater involvement of healthcare professionals in the governance ofc...
IDPH has a new grant-funded program, the Health Promotion and Chronic Disease Control Partnership. ...
David Nash is the Founding Dean and the Dr. Raymond C. and Doris N. Grandon Professor of Health Poli...
Despite widespread adoption of disease management (DM) programs by US health plans, gaps remain in t...
During the past decade, the profession of pharmacy has changed dramatically. The Doctor of Pharmacy ...
n the face of double-digit healthcare inflation, evidence of sys-temwide poor healthcare quality, an...
Despite many health reforms, the United States continues to struggle with limited healthcare access,...
David Nash, MD, MBA, is the Founding Dean and the Dr. Raymond C. and Doris N. Grandon Professor of H...
Disease Management (DM) programs for Medicaid patients with chronic diseases have become very popula...
IDPH has a new grant-funded program, the Health Promotion and Chronic Disease Control Partnership. ...
As David B. Nash, MD, MBA, takes the helm of Disease Management as Editor-in-Chief, the practice of ...
The 2005 Disease Management Colloquium was heald at Jefferson Medical College in Philadelphia on Jun...
The purpose of this article is to examine chief medical officers\u27 (CMOs) perception of disease ma...
David B. Nash is the Founding Dean of the Jefferson School of Population Health on the campus of Tho...
The successful management of diabetes with a goal of achieving near-normoglycemia requires patients ...
There is growing evidence that greater involvement of healthcare professionals in the governance ofc...
IDPH has a new grant-funded program, the Health Promotion and Chronic Disease Control Partnership. ...
David Nash is the Founding Dean and the Dr. Raymond C. and Doris N. Grandon Professor of Health Poli...
Despite widespread adoption of disease management (DM) programs by US health plans, gaps remain in t...
During the past decade, the profession of pharmacy has changed dramatically. The Doctor of Pharmacy ...
n the face of double-digit healthcare inflation, evidence of sys-temwide poor healthcare quality, an...
Despite many health reforms, the United States continues to struggle with limited healthcare access,...
David Nash, MD, MBA, is the Founding Dean and the Dr. Raymond C. and Doris N. Grandon Professor of H...
Disease Management (DM) programs for Medicaid patients with chronic diseases have become very popula...
IDPH has a new grant-funded program, the Health Promotion and Chronic Disease Control Partnership. ...